This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Tuesday's Late Winners & Losers

The most heavily traded stocks were mixed after the closing bell Tuesday, and leading the winners by a wide margin was San Diego-based biotech Cypress Bioscience (CYPB).

Shares rocketed 87.1% to $15.81 in extremely heavy trading after it and Forest Laboratories (FRX) announced positive results from a late-phase trial.

The companies said that milnacipran, which is already approved to treat depression, showed statistically significant results in treating fibromyalgia syndrome -- a chronic and painful condition that causes stiffness, severe fatigue and insomnia. Forest shares jumped 8.2% to $56.15.

Aluminum-products makers Alcan (AL) and Alcoa (AA) were up more than 2.5% each after Alcan's board unanimously rejected the latter's recent hostile takeout bid, worth roughly $27 billion in cash and stock.

Shanda Interactive Entertainment (SNDA), a China-based online-games developer, rose 3.4% to $29.60 after earning 36 cents per American depositary share (non-GAAP) in the first quarter. This is 7 cents higher than the average Wall Street estimate, according to Thomson Financial.

Minneapolis medical-equipment maker Medtronic (MDT - Get Report) climbed 3.3% to $52.47 after coming in 4 cents above the mean target with non-GAAP earnings of 66 cents a share, or $767 million, in the quarter ended April 27.

Semiconductor maker Advanced Analogic Technologies (AATI) of Sunnyvale, Calif., was also on the rise after announcing it had "prevailed" in a patent-infringement case brought by Linear Technology (LLTC - Get Report). AnalogicTech said all of Linear's claims were found "either non-infringed or invalid" in an "initial determination" by the International Trade Commission. The final determination should issue by Sept. 22. Linear, for its part, traded down 1% to $36.77 in recent extended trading.

Among others on the postclose downswing, Analog Devices (ADI - Get Report) fell after predicting fiscal third-quarter income of 37 cents to 41 cents a share (excluding items) on sales ranging between $655 million and $685 million, which leans to the lower end of consensus. The Norwood, Mass., semiconductor company bested targets for the quarter ended May 5, but shares still slid 6% to $38.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ADI $58.57 -0.53%
FRX $99.00 -0.77%
MDT $77.60 -1.50%
LLTC $48.19 -0.43%
AAPL $128.45 -1.50%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs